Paper37541219
FACS-based genome-wide CRISPR screens define key regulators of DNA damage signaling pathways.
Huang M and 15 others. Mol Cell, 2023. Cited by 24 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. FACS-based genome-wide CRISPR screens define key regulators of DNA damage signaling pathways. Papers, record 37541219. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37541219
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Clustered Regularly Interspaced Short Palindromic Repeats | Major topic |
| DNA Damage | Major topic |
| Humans | |
| Flow Cytometry | |
| Signal Transduction | |
| Ataxia Telangiectasia Mutated Proteins | |
| Genome | |
| Protein-Arginine N-Methyltransferases | |
| Repressor Proteins |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R35 GM130119 | NIGMS NIH HHS | United States | R35GM130119 | PubMed and NIH | NIH RePORTER |
| R01 CA275712 | NCI NIH HHS | United States | R01CA275712 | PubMed and NIH | NIH RePORTER |
| R01 CA216437 | NCI NIH HHS | United States | R01CA216437 | PubMed and NIH | NIH RePORTER |
| R01 CA216911 | NCI NIH HHS | United States | R01CA216911 | PubMed and NIH | NIH RePORTER |
| P01 CA193124 | NCI NIH HHS | United States | P01CA193124 | PubMed and NIH | NIH RePORTER |
| P30 CA016672 | NCI NIH HHS | United States | P30CA016672 | PubMed and NIH | NIH RePORTER |
| R01 CA210929 | NCI NIH HHS | United States | R01CA210929 | PubMed and NIH | NIH RePORTER |
| R01 CA278758 | NCI NIH HHS | United States | R01CA278758 | PubMed and NIH | NIH RePORTER |
| R35 CA274234 | NCI NIH HHS | United States | R35CA274234 | PubMed and NIH | NIH RePORTER |
References89
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34330913 | PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma. | Nat Commun | 2021 | https://conductscience.org/library/papers/34330913 | PubMed |
| 2 | 31257072 | Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss. | Cancer Cell | 2019 | https://conductscience.org/library/papers/31257072 | PubMed |
| 3 | 31230909 | PRMTs and Arginine Methylation: Cancer's Best-Kept Secret? | Trends Mol Med | 2019 | https://conductscience.org/library/papers/31230909 | PubMed |
| 4 | 23627586 | Human RECQL5: guarding the crossroads of DNA replication and transcription and providing backup capability. | Crit Rev Biochem Mol Biol | 2013 | https://conductscience.org/library/papers/23627586 | PubMed |
| 5 | 24845676 | DNA replication and oncogene-induced replicative stress. | Curr Biol | 2014 | https://conductscience.org/library/papers/24845676 | PubMed |
| 6 | 31884170 | PRMT5 Cooperates with pICln to Function as a Master Epigenetic Activator of DNA Double-Strand Break Repair Genes. | iScience | 2020 | https://conductscience.org/library/papers/31884170 | PubMed |
| 7 | 19011233 | Supportive evidence for reduced expression of GNB1L in schizophrenia. | Schizophr Bull | 2010 | https://conductscience.org/library/papers/19011233 | PubMed |
| 8 | 25260700 | HTSeq--a Python framework to work with high-throughput sequencing data. | Bioinformatics | 2015 | https://conductscience.org/library/papers/25260700 | PubMed |
| 9 | 9016654 | Transcriptional repression by RING finger protein TIF1 beta that interacts with the KRAB repressor domain of KOX1. | Nucleic Acids Res | 1996 | https://conductscience.org/library/papers/9016654 | PubMed |
| 10 | 32948771 | Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules. | Nat Commun | 2020 | https://conductscience.org/library/papers/32948771 | PubMed |
| 11 | 8986806 | A novel member of the RING finger family, KRIP-1, associates with the KRAB-A transcriptional repressor domain of zinc finger proteins. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8986806 | PubMed |
| 12 | 11080144 | Eukaryotic chaperonin CCT stabilizes actin and tubulin folding intermediates in open quasi-native conformations. | EMBO J | 2000 | https://conductscience.org/library/papers/11080144 | PubMed |
| 13 | 32459988 | Biomarker-Guided Development of DNA Repair Inhibitors. | Mol Cell | 2020 | https://conductscience.org/library/papers/32459988 | PubMed |
| 14 | 27912094 | Mre11 Is Essential for the Removal of Lethal Topoisomerase 2 Covalent Cleavage Complexes. | Mol Cell | 2016 | https://conductscience.org/library/papers/27912094 | PubMed |
| 15 | 20810650 | A genetic screen identifies the Triple T complex required for DNA damage signaling and ATM and ATR stability. | Genes Dev | 2010 | https://conductscience.org/library/papers/20810650 | PubMed |
| 16 | 8769649 | KAP-1, a novel corepressor for the highly conserved KRAB repression domain. | Genes Dev | 1996 | https://conductscience.org/library/papers/8769649 | PubMed |
| 17 | 17525332 | ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. | Science | 2007 | https://conductscience.org/library/papers/17525332 | PubMed |
| 18 | 19690144 | Intracellular beta-tubulin/chaperonin containing TCP1-beta complex serves as a novel chemotherapeutic target against drug-resistant tumors. | Cancer Res | 2009 | https://conductscience.org/library/papers/19690144 | PubMed |
| 19 | 28622525 | ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response. | Mol Cell | 2017 | https://conductscience.org/library/papers/28622525 | PubMed |
| 20 | 34983733 | Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition. | Drug Resist Updat | 2021 | https://conductscience.org/library/papers/34983733 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42824134 | Glutamine metabolism and its roles in tumor radiotherapy by regulating DNA damage repair. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42824134 | PubMed |
| 42696584 | Glucose-TOR-PDCB signaling restricts cell-to-cell communication through callose deposition. | Sci Adv | 2026 | https://conductscience.org/library/papers/42696584 | PubMed |
| 42518659 | Targeting ROAM1 with UDP-GlcNAc nanosheets selective activates lysosomal AMPK to resolve metabolic dysfunction-associated steatotic liver disease. | Bioact Mater | 2026 | https://conductscience.org/library/papers/42518659 | PubMed |
| 42484294 | CRISPR Screening Identifies SMARCAL1 and MRN as Modulators of WRN Dependency in MSI-H Colorectal Cancer. | Cancer Res | 2026 | https://conductscience.org/library/papers/42484294 | PubMed |
| 42448898 | PRMT5 inhibition disrupts detained intron splicing and impairs ATR signaling with increased DNA damage. | Commun Biol | 2026 | https://conductscience.org/library/papers/42448898 | PubMed |
| 42146330 | Parallel Activation and Interference CRISPR (PAIR) with Sequencing Uncovers DNA Repair Networks Guiding Precision Cell Engineering. | bioRxiv | 2026 | https://conductscience.org/library/papers/42146330 | PubMed |
| 42041999 | Methodological Landscape of DNA Damage Response Detection: From Conventional Assays to Future Innovations. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42041999 | PubMed |
| 41890907 | PRMT5 inhibition triggers functional ATM deficiency and sensitizes pancreatic cancer to CHK1 blockade. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/41890907 | PubMed |
| 41803859 | Inhibition of PRMT5 triggers synthetic lethality in ARID1A-deficient endometrial cancer by promoting aberrant R-loop accumulation. | Mol Cancer | 2026 | https://conductscience.org/library/papers/41803859 | PubMed |
| 41601654 | FACS-based genome-wide CRISPR screening platform identifies modulators of CD47. | Front Immunol | 2025 | https://conductscience.org/library/papers/41601654 | PubMed |
| 41580420 | Modulation of Nudt21 levels reveals dose-dependent roles of alternative polyadenylation in tissue regeneration. | Nat Commun | 2026 | https://conductscience.org/library/papers/41580420 | PubMed |
| 41000943 | Systematic identification and characterization of regulators of aryl hydrocarbon receptor signaling. | bioRxiv | 2025 | https://conductscience.org/library/papers/41000943 | PubMed |
| 40875132 | Revealing genetic drivers of ovarian cancer and chemoresistance: insights from whole-genome CRISPR-knockout library screens. | Cell Oncol (Dordr) | 2025 | https://conductscience.org/library/papers/40875132 | PubMed |
| 40848933 | Targeting DNA Topoisomerase I for the Treatment of Cancer: Past, Present and Future. | J Mol Biol | 2026 | https://conductscience.org/library/papers/40848933 | PubMed |
| 40679866 | Identification of Epigenetic Regulators of Vascular Calcification with a CRISPR-Based Screen. | J Am Soc Nephrol | 2025 | https://conductscience.org/library/papers/40679866 | PubMed |
| 40650785 | CRISPR screening approaches in breast cancer research. | Cancer Metastasis Rev | 2025 | https://conductscience.org/library/papers/40650785 | PubMed |
| 40578838 | Optimized derivation and culture system of human naïve pluripotent stem cells with enhanced DNA methylation status and genomic stability. | Protein Cell | 2025 | https://conductscience.org/library/papers/40578838 | PubMed |
| 40185091 | Variant-to-function approaches for adipose tissue: Insights into cardiometabolic disorders. | Cell Genom | 2025 | https://conductscience.org/library/papers/40185091 | PubMed |
| 40157940 | Genome-scale CRISPRi screen identifies pcnB repression conferring improved physiology for overproduction of free fatty acids in Escherichia coli. | Nat Commun | 2025 | https://conductscience.org/library/papers/40157940 | PubMed |
| 39778868 | Cell cycle progression of under-replicated cells. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/39778868 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GNB1L | 54584 | Swiss-Prot's references | https://conductscience.org/library/genes/54584 | NCBI Gene |
| ATM | 472 | PubTator's text mining | https://conductscience.org/library/genes/472 | NCBI Gene |
| PRMT1 | 3276 | PubTator's text mining | https://conductscience.org/library/genes/3276 | NCBI Gene |
| PRMT5 | 10419 | PubTator's text mining | https://conductscience.org/library/genes/10419 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37541219
GET https://conductscience.org/api/papers/v1/37541219/references?page=2